GSA Capital Partners’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
GSA Capital Partners's IMRX Position: Q3 2026 in Review
GSA Capital Partners reduced its Immuneering (IMRX) stake by 70% in Q3 2026, selling an estimated $1.14M and leaving 101,336 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #1192.
GSA Capital Partners first reported a position in IMRX in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.71M in Q2 2026. 131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- GSA Capital Partners held 101,336 shares of Immuneering worth $415K as of Q3 2026.
- GSA Capital Partners sold 241,967 Immuneering shares in Q3 2026, an estimated $1.14M.
- Immuneering made up 0.02% of GSA Capital Partners's portfolio in Q3 2026, its #1192 holding.
- GSA Capital Partners first reported a position in Immuneering in Q3 2022 and has held it in 6 quarters since.
- GSA Capital Partners's Immuneering position peaked at $1.71M in Q2 2026.
- 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.